Internal Medicine, Hematology & Oncology · Memphis, TN
NPI
1619198512
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
80 Humphreys Center Dr Ste 330
Memphis, TN, 38120
Phone (901) 752-6131
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
2,714 services
Medicare patients, 2024
423
Average age 74
Drug cost, 2024
$8.2M
2,376 prescriptions
Company payments, 2025
$12K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad Raza was code 99233 (hospital e&m - subsequent), 754 times for 126 patients. In total Muhammad Raza billed 2,714 services in 25 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 754 | 126 | $85.76 | $65K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 678 | 227 | $11.36 | $7,700 |
| 99214 Office E&M - Established | Facility | 650 | 209 | $66.38 | $43K |
| 99213 Office E&M - Established | Facility | 110 | 90 | $40.25 | $4,428 |
| 99223 Hospital E&M - Initial | Facility | 94 | 80 | $123.58 | $12K |
| 99214 Office E&M - Established | Office | 91 | 72 | $69.49 | $6,323 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 77 | 53 | $11.81 | $909 |
| 99215 Office E&M - Established | Facility | 70 | 48 | $105.80 | $7,406 |
| 99232 Hospital E&M - Subsequent | Facility | 66 | 42 | $57.63 | $3,804 |
| 99204 Office E&M - New | Facility | 32 | 32 | $87.72 | $2,807 |
| 99213 Office E&M - Established | Office | 19 | 19 | $47.44 | $901 |
| 99239 Hospital Discharge Management | Facility | 12 | 12 | $83.46 | $1,002 |
By year: 2022 $136K for 1,854 services; 2023 $127K for 1,864 services; 2024 $159K for 2,714 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad Raza prescribed most often to Medicare patients was Acyclovir, with 196 prescriptions and refills. In total Muhammad Raza wrote 2,376 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 196 | 282 | 56 | $2,432 |
| Eliquis Apixaban | 132 | 184 | 36 | $105K |
| Pantoprazole Sodium Generic | 100 | 146 | 34 | $895 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 85 | 85 | 22 | $2,387 |
| Calquence Acalabrutinib Maleate | 76 | 76 | Under 11 | $1.1M |
| Revlimid Lenalidomide | 75 | 75 | 11 | $1.2M |
| Ondansetron Hcl Generic | 68 | 70 | 31 | $541 |
| Prednisone Generic | 66 | 68 | 16 | $270 |
| Pomalyst Pomalidomide | 65 | 65 | 11 | $1.3M |
| Ondansetron Odt Ondansetron | 57 | 57 | 32 | $994 |
| Hydroxyurea Generic | 54 | 102 | 12 | $1,747 |
| Oxycodone Hcl Generic | 48 | 48 | 13 | $629 |
| Dexamethasone Generic | 48 | 50 | 24 | $909 |
| Lenalidomide Generic | 46 | 46 | Under 11 | $545K |
| Potassium Chloride Generic | 46 | 52 | 19 | $408 |
Brand drugs: 746 claims; generic drugs: 1,630 claims; opioid claims: 204.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad Raza $12K ($12K in general payments such as food, travel and fees) from 34 companies. The largest payer was Kite Pharma, Inc. with $9,662.
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. GILD | 11 | $9,662 |
| Janssen Biotech, Inc. JNJ | 11 | $346 |
| Abbvie Inc. ABBV | 9 | $198 |
| Pfizer Inc. PFE | 8 | $157 |
| Daiichi Sankyo Inc. 4568.T | 6 | $154 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $139 |
| Celgene Corporation BMY | 4 | $109 |
| Tempus AI, Inc TEM | 5 | $108 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $97.48 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $94.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.